Overview

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Status:
Unknown status
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Does treatment with bevacizumab (Avastin) in combination with prior or current radiotherapy lead to optic neuropathy?
Phase:
Early Phase 1
Details
Lead Sponsor:
West Penn Allegheny Health System
Treatments:
Bevacizumab